STEVIE VEGA: Open Payments
NPI 1073117248 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,581 in 77 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $540 · 2025 $1,581
Food & beverage: $1,581
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $231 |
| Neurocrine BioSciences, Inc. | 10 | $192 |
| PFIZER INC. | 9 | $184 |
| Novartis Pharmaceuticals Corporation | 8 | $178 |
| Axsome Therapeutics, Inc. | 7 | $146 |
| ACADIA Pharmaceuticals Inc | 6 | $121 |
| Amgen Inc. | 5 | $108 |
| UCB, Inc. | 4 | $85 |
| ARGENX US, INC. | 4 | $79 |
| Janssen Biotech, Inc. | 3 | $61 |
Products named: INGREZZA, NURTEC ODT, KESIMPTA, Symbravo, NUPLAZID, UBRELVY, Briviact, UPLIZNA.
Industry payments across AL — which companies pay providers there.
